Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours

NCT06430502 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Cancer
PD-L1 Gene Mutation

Interventions

BIOLOGICAL: Tumor Treatment Vaccine; PD-1/L1 inhibitors

Sponsor

Wuxi People's Hospital